CRP Correlates with Clinical Score in Ulcerative Colitis but Not in Crohn’s Disease

Abstract

The aim of this study was to prospectively evaluate the correlation between clinical scoring systems and C-reactive protein (CRP) in inflammatory bowel disease. The modified Harvey-Bradshaw index was used in 40 patients (58 assessments) with Crohn’s disease, and the Lichtiger score in 29 patients (36 assessments) with ulcerative colitis. In ulcerative colitis, CRP was elevated in 14%, 42%, 64%, and 83%, respectively, of subjects with quiescent, mild, moderate, and severe disease. There was a linear correlation of log(CRP) with clinical score except for proctitis. In Crohn’s disease, CRP was elevated in 54%, 70%, 75%, and 100%, respectively, of subjects with quiescent, mild, moderate, and severe disease. We conclude that the clinical score has a good correlation with CRP in ulcerative colitis except for proctitis, whereas clinical score has a poor correlation with CRP in Crohn’s disease, particularly in those with clinically quiescent, fibrostenotic, and ileal disease.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Camilleri M, Proana M (1989) Advances in the assessment of disease activity in inflammatory bowel disease. Mayo Clin Proc 64:800–807

    PubMed  CAS  Google Scholar 

  2. 2.

    Gomes P, du Boulay C, Smith CL, Holdstock G (1986) Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 27:92–95

    PubMed  CAS  Google Scholar 

  3. 3.

    Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJF, Chadwick VS (1986) Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease: a comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology 90:1121–1128

    PubMed  CAS  Google Scholar 

  4. 4.

    Papi C, Ciaco A, Bianchi M, Montani S, Koch M, Capurso L (1996) Correlation of various Crohn’s disease activity indexes in subgroups of patients with primarily inflammatory or fibrostenosing clinical characteristics. J Clin Gastroenterol 23:40–43

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Sachar DB, Smith H, Chan S, Cohen LB, Lichtiger S, Messer J (1986) Erythrocyte sedimentation rate as a measure of clinical activity in inflammatory bowel disease. J Clin Gastroenterol 8:647–650

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Prantera C, Davoli M, Lorenzetti R, Pallone F, Marcheggiano A, Iannoni C, Mariotti S (1988) Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most. J Clin Gastroenterol 10:41–45

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Fagan EA, Dyck RF, Maton PN, Hodgson HJF, Chadwick VS, Petrie A, Pepys MB (1989) Serum levels of C-reactive peptide in Crohn’s disease and ulcerative colitis. Eur J Clin Invest 12:351–359

    Article  Google Scholar 

  8. 8.

    Sachar DB, Luppescu NE, Bodian C, Shlien RD, Fabry TL, Gumaste VV (1990) Erythrocyte sedimentation as a measure of Crohn’s disease activity: opposite trends in ileitis versus colitis. J Clin Gastroenterol 12:643–646

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Best WR, Becktel JM, Singleton JW, Kern Jr F (1976) Development of a Crohn’s disease activity index: National Cooperative Crohn’s Disease Study. Gastroenterology 70:439–444

    PubMed  CAS  Google Scholar 

  10. 10.

    Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330:1841–1845

    PubMed  Article  CAS  Google Scholar 

  11. 11.

    Harvey RF, Bradshaw JM (1980) A simple index of Crohn’s disease activity. Lancet 1:514

    PubMed  Article  CAS  Google Scholar 

  12. 12.

    Talstad I, Gjone E (1976) The disease activity of ulcerative colitis and Crohn’s disease. Scand J Gastroenterol 11:403–408

    PubMed  CAS  Google Scholar 

  13. 13.

    Dearing WH, McGuckin WH, Elveback LR (1986) Serum alpha 1-acid glycoprotein in chronic ulcerative colitis. Gastroenterology 56:295–303

    Google Scholar 

  14. 14.

    Cooke WT, Prior P (1984) Determining disease activity in inflammatory bowel disease. J Clin Gastroenterol 6:17–25

    PubMed  CAS  Google Scholar 

  15. 15.

    Talstasd I, Gjone E (1976) The disease activity of ulcerative colitis and Crohn’s disease. Scand J Gastroenterol 11:403–408

    Google Scholar 

  16. 16.

    Florin TH, Paterson EW, Fowler EV, Radford-Smith GL (2006) Clinically active Crohn’s disease in the presence of a low C-reactive protein. Scand J Gastroenterol 41:306–311

    PubMed  Article  CAS  Google Scholar 

  17. 17.

    Savermyuttu SH, Hodgson HJF, Chadwick VS, Pepys MB (1986) Differing acute phase responses in Crohn’s disease and ulcerative colitis. Gut 27:809–813

    Google Scholar 

  18. 18.

    Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: Useful magic, or unnecessary toys? Gut 55:426–432

    PubMed  Article  CAS  Google Scholar 

  19. 19.

    Chamouard P, Richert Z, Meyer N, Rahmi G, Bauman R (2006) Diagnostic value of C-reactive protein for predicting activity level of Crohn’s disease. Clin Gastroenterol Hepatol 4:882–887

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Adrian G. Cummins.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rodgers, A.D., Cummins, A.G. CRP Correlates with Clinical Score in Ulcerative Colitis but Not in Crohn’s Disease. Dig Dis Sci 52, 2063–2068 (2007). https://doi.org/10.1007/s10620-006-9691-2

Download citation

Keywords

  • C-reactive protein
  • Crohn’s disease
  • Erythrocyte sedimentation rate
  • Inflammatory bowel disease
  • Ulcerative colitis